{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:36:38Z","timestamp":1793939798128,"version":"4.8.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2006,7,19]],"date-time":"2006-07-19T00:00:00Z","timestamp":1153267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1007\/s00125-006-0351-z","type":"journal-article","created":{"date-parts":[[2006,7,18]],"date-time":"2006-07-18T07:21:27Z","timestamp":1153207287000},"page":"2086-2096","source":"Crossref","is-referenced-by-count":100,"title":["Leptin and incident type 2 diabetes: risk or protection?"],"prefix":"10.1007","volume":"49","author":[{"given":"M. I.","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. B.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Vigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. S.","family":"Pankow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Couper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. M.","family":"Ballantyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. C.","family":"Hoogeveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Heiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"For the ARIC Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,7,19]]},"reference":[{"key":"351_CR1","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0140-6736(99)01046-6","volume":"353","author":"MI Schmidt","year":"1999","unstructured":"Schmidt MI, Duncan BB, Sharrett AR et al (1999) Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 353:1649\u20131652","journal-title":"Lancet"},{"key":"351_CR2","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2337\/diabetes.52.7.1799","volume":"52","author":"BB Duncan","year":"2003","unstructured":"Duncan BB, Schmidt MI, Pankow JS et al (2003) Low-grade systemic inflammation and the development of type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes 52:1799\u20131805","journal-title":"Diabetes"},{"key":"351_CR3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1089\/dia.2006.8.7","volume":"8","author":"BB Duncan","year":"2006","unstructured":"Duncan BB, Schmidt MI (2006) The epidemiology of low-grade chronic systemic inflammation and type 2 diabetes. Diabetes Technol Ther 8:7\u201317","journal-title":"Diabetes Technol Ther"},{"key":"351_CR4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nri1350","volume":"4","author":"A Cava La","year":"2004","unstructured":"La Cava A, Matarese G (2004) The weight of leptin in immunity. Nat Rev Immunol 4:371\u2013379","journal-title":"Nat Rev Immunol"},{"key":"351_CR","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.plipres.2004.03.001","volume":"43","author":"F Peelman","year":"2004","unstructured":"Peelman F, Waelput W, Iserentant H et al (2004) Leptin: linking adipocyte metabolism with cardiovascular and autoimmune diseases. Prog Lipid Res 43:283\u2013301","journal-title":"Prog Lipid Res"},{"key":"351_CR6","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.biocel.2005.09.013","volume":"38","author":"BO Yildiz","year":"2006","unstructured":"Yildiz BO, Haznedaroglu IC (2006) Rethinking leptin and insulin action: therapeutic opportunities for diabetes. Int J Biochem Cell Biol 38:820\u2013830","journal-title":"Int J Biochem Cell Biol"},{"key":"351_CR7","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/sj.ijo.0803025","volume":"29","author":"RB Ceddia","year":"2005","unstructured":"Ceddia RB (2005) Direct metabolic regulation in skeletal muscle and fat tissue by leptin: implications for glucose and fatty acids homeostasis. Int J Obes (Lond) 29:1175\u20131183","journal-title":"Int J Obes (Lond)"},{"key":"351_CR8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2337\/diacare.22.1.65","volume":"22","author":"MJ McNeely","year":"1999","unstructured":"McNeely MJ, Boyko EJ, Weigle DS et al (1999) Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care 22:65\u201370","journal-title":"Diabetes Care"},{"key":"351_CR9","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.2337\/diacare.23.9.1242","volume":"23","author":"EJ Boyko","year":"2000","unstructured":"Boyko EJ, de Courten M, Zimmet PZ, Chitson P, Tuomilehto J, Alberti KG (2000) Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance: a prospective study in Mauritius. Diabetes Care 23:1242\u20131248","journal-title":"Diabetes Care"},{"key":"351_CR10","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/oby.2005.178","volume":"13","author":"PW Franks","year":"2005","unstructured":"Franks PW, Brage S, Luan J et al (2005) Leptin predicts a worsening of the features of the metabolic syndrome independently of obesity. Obes Res 13:1476\u20131484","journal-title":"Obes Res"},{"key":"351_CR11","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1096\/fj.02-0158rev","volume":"16","author":"RB Ceddia","year":"2002","unstructured":"Ceddia RB, Koistinen HA, Zierath JR, Sweeney G (2002) Analysis of paradoxical observations on the association between leptin and insulin resistance. FASEB J 16:1163\u20131176","journal-title":"FASEB J"},{"key":"351_CR12","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.biocel.2005.11.008","volume":"38","author":"YF Zhao","year":"2006","unstructured":"Zhao YF, Feng DD, Chen C (2006) Contribution of adipocyte-derived factors to beta-cell dysfunction in diabetes. Int J Biochem Cell Biol 38:804\u2013819","journal-title":"Int J Biochem Cell Biol"},{"key":"351_CR13","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1073\/pnas.94.9.4637","volume":"94","author":"M Shimabukuro","year":"1997","unstructured":"Shimabukuro M, Koyama K, Chen G et al (1997) Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci USA 94:4637\u20134641","journal-title":"Proc Natl Acad Sci USA"},{"key":"351_CR14","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.2337\/diab.46.8.1360","volume":"46","author":"DM Muoio","year":"1997","unstructured":"Muoio DM, Dohm GL, Fiedorek FT Jr, Tapscott EB, Coleman RA, Dohn GL (1997) Leptin directly alters lipid partitioning in skeletal muscle. Diabetes 46:1360\u20131363","journal-title":"Diabetes"},{"key":"351_CR15","doi-asserted-by":"crossref","first-page":"9558","DOI":"10.1073\/pnas.95.16.9558","volume":"95","author":"M Shimabukuro","year":"1998","unstructured":"Shimabukuro M, Wang MY, Zhou YT, Newgard CB, Unger RH (1998) Protection against lipoapoptosis of beta cells through leptin-dependent maintenance of Bcl-2 expression. Proc Natl Acad Sci USA 95:9558\u20139561","journal-title":"Proc Natl Acad Sci USA"},{"key":"351_CR16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/415339a","volume":"415","author":"Y Minokoshi","year":"2002","unstructured":"Minokoshi Y, Kim YB, Peroni OD et al (2002) Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415:339\u2013343","journal-title":"Nature"},{"key":"351_CR17","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1210\/en.2005-0087","volume":"146","author":"Y Toyoshima","year":"2005","unstructured":"Toyoshima Y, Gavrilova O, Yakar S et al (2005) Leptin improves insulin resistance and hyperglycemia in a mouse model of type 2 diabetes. Endocrinology 146:4024\u20134035","journal-title":"Endocrinology"},{"key":"351_CR18","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nn1454","volume":"8","author":"H Munzberg","year":"2005","unstructured":"Munzberg H, Myers MG Jr (2005) Molecular and anatomical determinants of central leptin resistance. Nat Neurosci 8:566\u2013570","journal-title":"Nat Neurosci"},{"key":"351_CR19","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2337\/diabetes.54.4.985","volume":"54","author":"J Tong","year":"2005","unstructured":"Tong J, Fujimoto WY, Kahn SE et al (2005) Insulin, C-peptide, and leptin concentrations predict increased visceral adiposity at 5- and 10-year follow-ups in nondiabetic Japanese Americans. Diabetes 54:985\u2013990","journal-title":"Diabetes"},{"key":"351_CR20","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1210\/en.2005-0731","volume":"147","author":"W Huang","year":"2006","unstructured":"Huang W, Dedousis N, Bandi A, Lopaschuk GD, O\u2019Doherty RM (2006) Liver triglyceride secretion and lipid oxidative metabolism are rapidly altered by leptin in vivo. Endocrinology 147:1480\u20131487","journal-title":"Endocrinology"},{"key":"351_CR21","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jhep.2005.02.048","volume":"43","author":"XP Yang","year":"2005","unstructured":"Yang XP, Schaper F, Teubner A et al (2005) Interleukin-6 plays a crucial role in the hepatic expression of SOCS3 during acute inflammatory processes in vivo. J Hepatol 43:704\u2013710","journal-title":"J Hepatol"},{"key":"351_CR22","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/oxfordjournals.aje.a115184","volume":"129","author":"ARIC Investigators","year":"1989","unstructured":"ARIC Investigators (1989) The Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 129:687\u2013702","journal-title":"Am J Epidemiol"},{"key":"351_CR23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/biomet\/87.1.37","volume":"87","author":"DY Lin","year":"2000","unstructured":"Lin DY (2000) On fitting Cox\u2019s proportional hazards models to survey data. Biometrika 87:37\u201347","journal-title":"Biometrika"},{"key":"351_CR24","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-3115-3","volume-title":"Modelling survival data in medical research","author":"D Collett","year":"1994","unstructured":"Collett D (1994) Modelling survival data in medical research. Chapman & Hall, London"},{"key":"351_CR25","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.2337\/diabetes.53.9.2473","volume":"53","author":"BB Duncan","year":"2004","unstructured":"Duncan BB, Schmidt MI, Pankow J et al (2004) Adiponectin and the development of type 2 diabetes: the ARIC study. Diabetes 53:2473\u20132478","journal-title":"Diabetes"},{"key":"351_CR26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.mce.2005.07.003","volume":"242","author":"Y Benomar","year":"2005","unstructured":"Benomar Y, Wetzler S, Larue-Achagiotis C, Djiane J, Tome D, Taouis M (2005) In vivo leptin infusion impairs insulin and leptin signalling in liver and hypothalamus. Mol Cell Endocrinol 242:59\u201366","journal-title":"Mol Cell Endocrinol"},{"key":"351_CR27","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1172\/JCI119824","volume":"100","author":"TG Kirchgessner","year":"1997","unstructured":"Kirchgessner TG, Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS (1997) Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest 100:2777\u20132782","journal-title":"J Clin Invest"},{"key":"351_CR28","doi-asserted-by":"crossref","first-page":"27758","DOI":"10.1074\/jbc.272.44.27758","volume":"272","author":"L Rossetti","year":"1997","unstructured":"Rossetti L, Massillon D, Barzilai N et al (1997) Short term effects of leptin on hepatic gluconeogenesis and in vivo insulin action. J Biol Chem 272:27758\u201327763","journal-title":"J Biol Chem"},{"key":"351_CR29","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1096\/fj.04-2846fje","volume":"19","author":"G Brabant","year":"2005","unstructured":"Brabant G, Muller G, Horn R, Anderwald C, Roden M, Nave H (2005) Hepatic leptin signaling in obesity. FASEB J 19:1048\u20131050","journal-title":"FASEB J"},{"key":"351_CR30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1385\/ENDO:19:1:65","volume":"19","author":"N Sagawa","year":"2002","unstructured":"Sagawa N, Yura S, Itoh H et al (2002) Possible role of placental leptin in pregnancy: a review. Endocrine 19:65\u201371","journal-title":"Endocrine"},{"key":"351_CR31","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1042\/bst0311161","volume":"31","author":"M Guerre-Millo","year":"2003","unstructured":"Guerre-Millo M (2003) Extending the glucose\/fatty acid cycle: a glucose\/adipose tissue cycle. Biochem Soc Trans 31:1161\u20131164","journal-title":"Biochem Soc Trans"},{"key":"351_CR32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2337\/diab.46.2.313","volume":"46","author":"V Emilsson","year":"1997","unstructured":"Emilsson V, Liu YL, Cawthorne MA, Morton NM, Davenport M (1997) Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes 46:313\u2013316","journal-title":"Diabetes"},{"key":"351_CR33","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2337\/diab.46.6.1087","volume":"46","author":"TJ Kieffer","year":"1997","unstructured":"Kieffer TJ, Heller RS, Leech CA, Holz GG, Habener JF (1997) Leptin suppression of insulin secretion by the activation of ATP-sensitive K+ channels in pancreatic beta-cells. Diabetes 46:1087\u20131093","journal-title":"Diabetes"},{"key":"351_CR34","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1073\/pnas.0308258100","volume":"101","author":"L Orci","year":"2004","unstructured":"Orci L, Cook WS, Ravazzola M et al (2004) Rapid transformation of white adipocytes into fat-oxidizing machines. Proc Natl Acad Sci USA 101:2058\u20132063","journal-title":"Proc Natl Acad Sci USA"},{"key":"351_CR35","doi-asserted-by":"crossref","first-page":"2455S","DOI":"10.1093\/jn\/134.9.2455S","volume":"134","author":"P Cohen","year":"2004","unstructured":"Cohen P, Friedman JM (2004) Leptin and the control of metabolism: role for stearoyl-CoA desaturase-1 (SCD-1). J Nutr 134:2455S\u20132463S","journal-title":"J Nutr"},{"key":"351_CR36","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/1568008033340117","volume":"3","author":"P Cohen","year":"2003","unstructured":"Cohen P, Ntambi JM, Friedman JM (2003) Stearoyl-CoA desaturase-1 and the metabolic syndrome. Curr Drug Targets Immune Endocr Metabol Disord 3:271\u2013280","journal-title":"Curr Drug Targets Immune Endocr Metabol Disord"},{"key":"351_CR37","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1172\/JCI119865","volume":"100","author":"N Barzilai","year":"1997","unstructured":"Barzilai N, Wang J, Massilon D, Vuguin P, Hawkins M, Rossetti L (1997) Leptin selectively decreases visceral adiposity and enhances insulin action. J Clin Invest 100:3105\u20133110","journal-title":"J Clin Invest"},{"key":"351_CR38","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1210\/en.2003-0870","volume":"144","author":"RH Unger","year":"2003","unstructured":"Unger RH (2003) Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 144:5159\u20135165","journal-title":"Endocrinology"},{"key":"351_CR39","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.2337\/diabetes.54.12.3530","volume":"54","author":"SY Park","year":"2005","unstructured":"Park SY, Cho YR, Kim HJ et al (2005) Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL\/6 mice. Diabetes 54:3530\u20133540","journal-title":"Diabetes"},{"key":"351_CR40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1472-6823-5-10","volume":"5","author":"T Jonsson","year":"2005","unstructured":"Jonsson T, Olsson S, Ahren B, Bog-Hansen TC, Dole A, Lindeberg S (2005) Agrarian diet and diseases of affluence\u2014do evolutionary novel dietary lectins cause leptin resistance? BMC Endocr Disord 5:10","journal-title":"BMC Endocr Disord"},{"key":"351_CR41","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2265.2005.02195.x","volume":"62","author":"P Magni","year":"2005","unstructured":"Magni P, Liuzzi A, Ruscica M et al (2005) Free and bound plasma leptin in normal weight and obese men and women: relationship with body composition, resting energy expenditure, insulin-sensitivity, lipid profile and macronutrient preference. Clin Endocrinol (Oxf) 62:189\u2013196","journal-title":"Clin Endocrinol (Oxf)"},{"key":"351_CR42","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2337\/diacare.22.3.413","volume":"22","author":"C Fox","year":"1999","unstructured":"Fox C, Esparza J, Nicolson M et al (1999) Plasma leptin concentrations in Pima Indians living in drastically different environments. Diabetes Care 22:413\u2013417","journal-title":"Diabetes Care"},{"key":"351_CR43","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1210\/jc.2002-021426","volume":"88","author":"PW Franks","year":"2003","unstructured":"Franks PW, Farooqi IS, Luan J et al (2003) Does physical activity energy expenditure explain the between-individual variation in plasma leptin concentrations after adjusting for differences in body composition? J Clin Endocrinol Metab 88:3258\u20133263","journal-title":"J Clin Endocrinol Metab"},{"key":"351_CR44","doi-asserted-by":"crossref","first-page":"10034","DOI":"10.1074\/jbc.M413684200","volume":"280","author":"P Cohen","year":"2005","unstructured":"Cohen P, Yang G, Yu X et al (2005) Induction of leptin receptor expression in the liver by leptin and food deprivation. J Biol Chem 280:10034\u201310039","journal-title":"J Biol Chem"},{"key":"351_CR45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.biochi.2004.11.014","volume":"87","author":"RH Unger","year":"2005","unstructured":"Unger RH (2005) Longevity, lipotoxicity and leptin: the adipocyte defense against feasting and famine. Biochimie 87:57\u201364","journal-title":"Biochimie"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-006-0351-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-006-0351-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-006-0351-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T11:45:53Z","timestamp":1558611953000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-006-0351-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,19]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["351"],"URL":"https:\/\/doi.org\/10.1007\/s00125-006-0351-z","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,19]]}}}